126 related articles for article (PubMed ID: 9849857)
1. The influence of p53 and associated factors on the outcome of patients with oral squamous cell carcinoma.
Stoll C; Baretton G; Löhrs U
Virchows Arch; 1998 Nov; 433(5):427-33. PubMed ID: 9849857
[TBL] [Abstract][Full Text] [Related]
2. Expression of p21/waf1 in oral squamous cell carcinomas--correlation with p53 and mdm2 and cellular proliferation index.
Ng IO; Lam KY; Ng M; Regezi JA
Oral Oncol; 1999 Jan; 35(1):63-9. PubMed ID: 10211312
[TBL] [Abstract][Full Text] [Related]
3. Prognostic significance of apoptosis and associated factors in oral squamous cell carcinoma.
Stoll C; Baretton G; Ahrens C; Löhrs U
Virchows Arch; 2000 Feb; 436(2):102-8. PubMed ID: 10755598
[TBL] [Abstract][Full Text] [Related]
4. Expression of p53 and p21 proteins in oral squamous cell carcinoma: correlation with lymph node metastasis and response to chemoradiotherapy.
Tatemoto Y; Osaki T; Yoneda K; Yamamoto T; Ueta E; Kimura T
Pathol Res Pract; 1998; 194(12):821-30. PubMed ID: 9894247
[TBL] [Abstract][Full Text] [Related]
5. MDM2/p53 co-expression in oral premalignant and malignant lesions: potential prognostic implications.
Agarwal S; Mathur M; Srivastava A; Ralhan R
Oral Oncol; 1999 Mar; 35(2):209-16. PubMed ID: 10435158
[TBL] [Abstract][Full Text] [Related]
6. In squamous cell carcinoma of the vulva, overexpression of p53 is a late event and neither p53 nor mdm2 expression is a useful marker to predict lymph node metastases.
Emanuels AG; Koudstaal J; Burger MP; Hollema H
Br J Cancer; 1999 Apr; 80(1-2):38-43. PubMed ID: 10389975
[TBL] [Abstract][Full Text] [Related]
7. Decreased expression of Bax is correlated with poor prognosis in oral and oropharyngeal carcinoma.
Ito T; Fujieda S; Tsuzuki H; Sunaga H; Fan G; Sugimoto C; Fukuda M; Saito H
Cancer Lett; 1999 Jun; 140(1-2):81-91. PubMed ID: 10403545
[TBL] [Abstract][Full Text] [Related]
8. Biological indicators of survival in patients treated by surgery for squamous cell carcinoma of the oral cavity and oropharynx.
Veneroni S; Silvestrini R; Costa A; Salvatori P; Faranda A; Molinari R
Oral Oncol; 1997 Nov; 33(6):408-13. PubMed ID: 9509124
[TBL] [Abstract][Full Text] [Related]
9. p53, mdm2, and p21 expression in oral squamous cell carcinomas: relationship with clinicopathologic factors.
Yanamoto S; Kawasaki G; Yoshitomi I; Mizuno A
Oral Surg Oral Med Oral Pathol Oral Radiol Endod; 2002 Nov; 94(5):593-600. PubMed ID: 12424454
[TBL] [Abstract][Full Text] [Related]
10. Immunohistochemical expression of p53, bcl-2, and p21(WAF1/CIP1) in early cervical carcinoma: correlation with clinical outcome.
Graflund M; Sorbe B; Karlsson M
Int J Gynecol Cancer; 2002; 12(3):290-8. PubMed ID: 12060451
[TBL] [Abstract][Full Text] [Related]
11. p53, p21, Rb, and MDM2 proteins in tongue carcinoma from patients < 35 versus > 75 years.
Regezi JA; Dekker NP; McMillan A; Ramirez-Amador V; Meneses-Garcia A; Ruiz-Godoy Rivera LM; Chrysomali E; Ng IO
Oral Oncol; 1999 Jul; 35(4):379-83. PubMed ID: 10645402
[TBL] [Abstract][Full Text] [Related]
12. The prognostic impact of metastatic pattern of lymph nodes in patients with oral and oropharyngeal squamous cell carcinomas.
Wenzel S; Sagowski C; Kehrl W; Metternich FU
Eur Arch Otorhinolaryngol; 2004 May; 261(5):270-5. PubMed ID: 14504863
[TBL] [Abstract][Full Text] [Related]
13. p53 expression in CMV-infected cells: association with the alternative expression of the p53 transactivated genes p21/WAF1 and MDM2.
García JF; Piris MA; Lloret E; Orradre JL; Murillo PG; Martínez JC
Histopathology; 1997 Feb; 30(2):120-5. PubMed ID: 9067734
[TBL] [Abstract][Full Text] [Related]
14. Immunohistochemical inactivation of p14ARF concomitant with MDM2 overexpression inversely correlates with p53 overexpression in oral squamous cell carcinoma.
Sano T; Hikino T; Xue Q; Saito T; Kashiwabara K; Oyama T; Nakajima T
Pathol Int; 2000 Sep; 50(9):709-16. PubMed ID: 11012984
[TBL] [Abstract][Full Text] [Related]
15. Alterations affecting the p53 control pathway in bilharzial-related bladder cancer.
Osman I; Scher HI; Zhang ZF; Pellicer I; Hamza R; Eissa S; Khaled H; Cordon-Cardo C
Clin Cancer Res; 1997 Apr; 3(4):531-6. PubMed ID: 9815716
[TBL] [Abstract][Full Text] [Related]
16. Clinical relevance of immunohistochemical expression of p53-targeted gene products mdm-2, p21 and bcl-2 in breast carcinoma.
Bánkfalvi A; Tory K; Kemper M; Breukelmann D; Cubick C; Poremba C; Füzesi L; Lellè RJ; Böcker W
Pathol Res Pract; 2000; 196(7):489-501. PubMed ID: 10926327
[TBL] [Abstract][Full Text] [Related]
17. Proliferative activity and loss of function of tumour suppressor genes as 'biomarkers' in diagnosis and prognosis of benign and preneoplastic oral lesions and oral squamous cell carcinoma.
Girod SC; Pfeiffer P; Ries J; Pape HD
Br J Oral Maxillofac Surg; 1998 Aug; 36(4):252-60. PubMed ID: 9762452
[TBL] [Abstract][Full Text] [Related]
18. P21/waf1 protein expression in nasopharyngeal carcinoma. Comparative study with PCNA, p53 and MDM-2 protein expression.
Kouvidou C; Stefanaki K; Dai Y; Tzardi M; Koutsoubi K; Darivianaki K; Karidi E; Rontogianni D; Zois E; Kakolyris S; Georgoulias V; Delides G; Kanavaros P
Anticancer Res; 1997; 17(4A):2615-9. PubMed ID: 9252690
[TBL] [Abstract][Full Text] [Related]
19. The unexplained survival of cells in oral cancer: what is the role of p53?
Whyte DA; Broton CE; Shillitoe EJ
J Oral Pathol Med; 2002 Mar; 31(3):125-33. PubMed ID: 11903817
[TBL] [Abstract][Full Text] [Related]
20. Expression of p21WAF1/CIP1 is unrelated to p53 tumour suppressor gene status in oral squamous cell carcinomas.
Yook JI; Kim J
Oral Oncol; 1998 May; 34(3):198-203. PubMed ID: 9692054
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
